Tender detail

Supply of enfortumab vedotin 30 mg for B.141 treatment of patients with urothelial cancer

Summary

The University Clinical Hospital in Poznań is procuring enfortumab vedotin in a 30 mg dose for the B.141 programme treating patients with urothelial cancer. The notice does not specify the quantity or divide the procurement into lots.

Reference number
2026/BZP 00496166/01
Buyer
Uniwersytecki Szpital Kliniczny w Poznaniu
Country
Poland (POL)
Procedure
Basic procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-10-27
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
POL_BZP

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.